AMEH - Apollo Medical Holdings, Inc.
NASDAQ
->
Healthcare
->
Medical Care Facilities
Alhambra,
United States
Type: Equity
AMEH price evolution
AMEH
| (in millions $) | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $273.94 | $294.27 | $274.61 | $288.03 |
| Short term investments | $3.99 | $4.76 | $5.09 | $8.69 |
| Net receivables | $184.34 | $150.95 | $155.81 | $126.75 |
| Inventory | ||||
| Total current assets | $476.23 | $465.06 | $457.69 | $435.14 |
| Long term investments | $72.71 | $48.73 | $44 | $41.2 |
| Property, plant & equipment | $150.06 | $141.76 | $131.79 | $128.98 |
| Goodwill & intangible assets | $349.74 | $348.45 | $353.7 | $352.54 |
| Total noncurrent assets | $597.03 | $562.11 | $534.94 | $528.77 |
| Total investments | $76.7 | $53.49 | $49.09 | $49.88 |
| Total assets | $1073.26 | $1027.18 | $992.63 | $963.9 |
| Current liabilities | ||||
| Accounts payable | $59.39 | $58.51 | $58.46 | $25.48 |
| Deferred revenue | ||||
| Short long term debt | $7.17 | $6.25 | $4.43 | $4.79 |
| Total current liabilities | $202.96 | $185.79 | $164.95 | $147.33 |
| Long term debt | $228.41 | $224.07 | $224.24 | $204.66 |
| Total noncurrent liabilities | $254.66 | $257.78 | $249.75 | $247.88 |
| Total debt | $235.59 | $230.31 | $228.68 | $229.36 |
| Total liabilities | $457.62 | $443.58 | $414.7 | $411.08 |
| Shareholders' equity | ||||
| Retained earnings | $230.78 | $208.72 | $207.3 | $192.68 |
| Other shareholder equity | ||||
| Total shareholder equity | $593.71 | $566.01 | $560.04 | $552.82 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $288.03 | $233.1 | $193.47 | $103.26 |
| Short term investments | $8.69 | $57.42 | $67.75 | $139.46 |
| Net receivables | $126.75 | $89.63 | $60.62 | $76.03 |
| Inventory | ||||
| Total current assets | $435.14 | $398.78 | $338.58 | $329.07 |
| Long term investments | $41.2 | $43.18 | $85.49 | $30.07 |
| Property, plant & equipment | $128.98 | $68.63 | $48.46 | $26.38 |
| Goodwill & intangible assets | $352.54 | $335.85 | $326.04 | $341.52 |
| Total noncurrent assets | $528.77 | $453.58 | $478.91 | $399.64 |
| Total investments | $49.88 | $100.6 | $153.24 | $169.53 |
| Total assets | $963.9 | $852.36 | $817.49 | $728.71 |
| Current liabilities | ||||
| Accounts payable | $25.48 | $54.48 | $45.78 | $29.31 |
| Deferred revenue | ||||
| Short long term debt | $4.79 | $3.9 | $14.17 | $12.59 |
| Total current liabilities | $147.33 | $115.37 | $114.99 | $105.42 |
| Long term debt | $204.66 | $197.09 | $246.39 | $243.96 |
| Total noncurrent liabilities | $247.88 | $220.99 | $257.35 | $262.23 |
| Total debt | $229.36 | $200.98 | $260.56 | $256.55 |
| Total liabilities | $411.08 | $336.36 | $372.34 | $367.65 |
| Shareholders' equity | ||||
| Retained earnings | $192.68 | $143.63 | $69.77 | $31.9 |
| Other shareholder equity | $0.09 | $0.79 | ||
| Total shareholder equity | $552.82 | $454.55 | $330.82 | $192.34 |
| (in millions $) | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $348.21 | $337.24 | $294.21 | |
| Cost of revenue | $292.88 | $289.4 | $253.12 | |
| Gross Profit | $55.33 | $47.85 | $41.09 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $24.06 | $21.18 | $24.45 | |
| Total operating expenses | $28.3 | $25.47 | $28.51 | |
| Operating income | $27.03 | $22.37 | $12.58 | |
| Income from continuing operations | ||||
| EBIT | $30.81 | $22.99 | $9.96 | |
| Income tax expense | $14.01 | $5.1 | $9.98 | |
| Interest expense | $3.63 | $3.27 | $2.57 | |
| Net income | ||||
| Net income | $13.17 | $14.62 | -$2.6 | |
| Income (for common shares) | $13.17 | $14.62 | -$2.6 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1144.16 | $773.91 | $687.18 | $560.62 |
| Cost of revenue | $944.68 | $596.14 | $539.21 | $467.8 |
| Gross Profit | $199.48 | $177.77 | $147.97 | $92.81 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $77.67 | $62.08 | $49.12 | $41.48 |
| Total operating expenses | $95.21 | $79.59 | $67.47 | $60.39 |
| Operating income | $104.27 | $98.18 | $80.5 | $32.42 |
| Income from continuing operations | ||||
| EBIT | $93.05 | $107.71 | $103.47 | $27.02 |
| Income tax expense | $36.09 | $28.45 | $56.11 | $8.17 |
| Interest expense | $7.92 | $5.39 | $9.5 | $4.73 |
| Net income | ||||
| Net income | $49.05 | $73.86 | $37.87 | $14.12 |
| Income (for common shares) | $49.05 | $73.86 | $37.87 | $14.12 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | $22.06 | $13.17 | $14.62 | -$2.6 |
| Operating activities | ||||
| Depreciation | $4.3 | $4.25 | $4.29 | $4.06 |
| Business acquisitions & disposals | -$4.97 | $0.35 | $2.14 | -$10.72 |
| Stock-based compensation | $5.71 | $4.21 | $3.44 | $5.62 |
| Total cash flows from operations | $15.4 | $25.8 | $7.72 | $84.94 |
| Investing activities | ||||
| Capital expenditures | -$4.11 | -$2.52 | -$14.85 | -$0.89 |
| Investments | -$25.8 | -$3.02 | -$1.32 | $24.81 |
| Total cash flows from investing | -$34.88 | -$5.19 | -$14.04 | $13.2 |
| Financing activities | ||||
| Dividends paid | -$1.42 | -$0.72 | -$0.12 | -$1.35 |
| Sale and purchase of stock | -$0.15 | -$8.29 | $6.25 | |
| Net borrowings | $1.06 | -$0.19 | $1.31 | $1.32 |
| Total cash flows from financing | -$0.51 | -$0.96 | -$7.1 | $5.87 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$19.98 | $19.65 | -$13.41 | $104.01 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | $49.05 | $73.86 | $37.87 | $14.12 |
| Operating activities | ||||
| Depreciation | $17.54 | $17.52 | $18.35 | $18.75 |
| Business acquisitions & disposals | -$12.29 | -$2.53 | $5.15 | -$49.4 |
| Stock-based compensation | $16.1 | $6.75 | $3.38 | $1.55 |
| Total cash flows from operations | $82.13 | $70.33 | $46.16 | $13.67 |
| Investing activities | ||||
| Capital expenditures | -$22.94 | -$19.22 | -$1.11 | -$1.04 |
| Investments | $28.11 | $32.37 | $91.46 | -$130.19 |
| Total cash flows from investing | -$7.11 | $16.54 | $95.49 | -$180.63 |
| Financing activities | ||||
| Dividends paid | -$14.03 | -$31.09 | -$51.32 | -$61.72 |
| Sale and purchase of stock | -$0.62 | $43.46 | -$0.54 | -$6.81 |
| Net borrowings | -$0.83 | -$57.97 | -$9.61 | $234.48 |
| Total cash flows from financing | -$20.09 | -$47.75 | -$51.7 | $163.33 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $54.93 | $39.13 | $89.96 | -$3.63 |
News
Fundamentals
| Market cap | $1.71B |
|---|---|
| Enterprise value | $1.67B |
| Shares outstanding | 46.60M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 2.88 |
| Book/Share | 12.74 |
| Cash/Share | 5.88 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.74 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.35 |
| Quick ratio | 2.35 |